In three clinical trials, intensive insulin therapy—when compared to conventional insulin therapy—consistently increased the risk of hypoglycemia in moderate to severe TBI patients and failed to decrease mortality at 6 months (160–162). This evidence concerns the gene INS and Hypoglycemia.